Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
DNA damage is able to induce senescence in tumor cells in vitro and in vivo.
te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. te Poele RH, et al. Among authors: joel sp. Cancer Res. 2002 Mar 15;62(6):1876-83. Cancer Res. 2002. PMID: 11912168
Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide.
Hucks D, Thompson PI, McLoughlin L, Joel SP, Patel N, Grossman A, Rees LH, Slevin ML. Hucks D, et al. Among authors: joel sp. Br J Cancer. 1992 Jan;65(1):122-6. doi: 10.1038/bjc.1992.23. Br J Cancer. 1992. PMID: 1310249 Free PMC article.
The comparative clinical pharmacology of vincristine and vindesine: does vindesine offer any advantage in clinical use?
Joel S. Joel S. Cancer Treat Rev. 1996 Nov;21(6):513-25. doi: 10.1016/0305-7372(95)90015-2. Cancer Treat Rev. 1996. PMID: 8599802 Review. No abstract available.
A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.
Downer S, Joel S, Allbright A, Plant H, Stubbs L, Talbot D, Slevin M. Downer S, et al. Br J Cancer. 1993 May;67(5):1102-5. doi: 10.1038/bjc.1993.202. Br J Cancer. 1993. PMID: 8494706 Free PMC article. Clinical Trial.
A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.
Philip PA, Joel S, Monkman SC, Dolega-Ossowski E, Tonkin K, Carmichael J, Idle JR, Harris AL. Philip PA, et al. Br J Cancer. 1992 Feb;65(2):267-70. doi: 10.1038/bjc.1992.53. Br J Cancer. 1992. PMID: 1739628 Free PMC article. Clinical Trial.
A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer.
Joel S, O'Byrne K, Penson R, Papamichael D, Higgins A, Robertshaw H, Rudd R, Talbot D, Slevin M. Joel S, et al. Ann Oncol. 1998 Nov;9(11):1205-11. doi: 10.1023/a:1008437805286. Ann Oncol. 1998. PMID: 9862051 Clinical Trial.
The clinical pharmacology of etoposide: an update.
Joel S. Joel S. Cancer Treat Rev. 1996 May;22(3):179-221. doi: 10.1016/s0305-7372(96)90002-x. Cancer Treat Rev. 1996. PMID: 8841390 Review. No abstract available.
In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma.
Shamash J, Salam AH, Davies DC, Williams A, Joel S, Lister TA. Shamash J, et al. Br J Cancer. 1998 May;77(10):1598-603. doi: 10.1038/bjc.1998.262. Br J Cancer. 1998. PMID: 9635834 Free PMC article.
Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines.
te Poele RH, Joel SP. te Poele RH, et al. Among authors: joel sp. Br J Cancer. 1999 Dec;81(8):1285-93. doi: 10.1038/sj.bjc.6694370. Br J Cancer. 1999. PMID: 10604724 Free PMC article.
Effects of haemopoietic growth factors in combination with etoposide on sister chromatid exchange frequencies in peripheral blood mononuclear cells.
Liu WM, Bamford C, Slevin M, Joel SP. Liu WM, et al. Among authors: joel sp. Cancer Chemother Pharmacol. 1998;41(4):343-6. doi: 10.1007/s002800050749. Cancer Chemother Pharmacol. 1998. PMID: 9488605
65 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback